Evaluating Patient Health Outcomes in Rare Diseases

Hastings Investigator: Sarah McGraw

Subcontract from Brigham and Women’s Hospital

The purpose of this project was to plan and carry out a symposium and write a journal supplement on research methods for understanding health outcomes in rare diseases. Dr. McGraw conducted focus groups with patient representatives, eliciting their views about what innovative methods exist – and what methods are needed – to assess the effectiveness and safety of rare disease therapeutics. She carried out a qualitative analysis and collaborated with a team at Brigham and Women’s Hospital to produce a manuscript on the findings, “Development and Use of Therapeutics for Rare Diseases: Views from Patients, Caregivers, and Advocates,” The Patient, February 2015.

The Hastings Center has never shied away from the toughest ethical challenges faced by society.



This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.